Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
212 participants
INTERVENTIONAL
2022-04-07
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technology/Digital Media Use and Children's Word Learning Development
NCT05403528
What Makes a Cup, a Cup? Generalizing Novel Words
NCT05443399
The Effect of Prior Learning on Word Learning
NCT05921188
Impact of Exposure to Television and Electronic Devices on Attention and Language in Children
NCT05659238
Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule
NCT06995014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3D-3D
All items presented in 3D form
No interventions assigned to this group
3D-2D
Initial items in 3D, generalization in 2D
Modality - 3D-2D
Modality in which items will be presented (via tablet/digital media or as real object). 3D items initially and generalization as 2D
2D-3D
Initial items in 2D, generalization in 3D
Modality - 2D-3D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 3D
2D-2D
Initial items in 2D, generalization in 2D
Modality - 2D-2D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and retention/generalization as 2D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modality - 3D-2D
Modality in which items will be presented (via tablet/digital media or as real object). 3D items initially and generalization as 2D
Modality - 2D-3D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 3D
Modality - 2D-2D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and retention/generalization as 2D
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* exposure to more than 25% of another language
17 Months
30 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Oklahoma State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Kucker
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oklahoma State University
Stillwater, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS-18-155B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.